A framework to rank genomic alterations as targets for cancer precision medicine: the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT)More about Open Access at the Crick
Authors listJ Mateo D Chakravarty R Dienstmann S Jezdic A Gonzalez-Perez N Lopez-Bigas CKY Ng PL Bedard G Tortora JY Douillard EM Van Allen N Schultz Charles Swanton F André L Pusztai
In order to facilitate implementation of precision medicine in clinical management of cancer, there is a need to harmonise and standardise the reporting and interpretation of clinically relevant genomics data.
Journal Annals of Oncology
Issue number 9